AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,214,769 | +54.2% | 419,430 | +42.3% | 0.01% | +50.0% |
| Q2 2023 | $13,757,769 | +50.9% | 294,662 | +23.6% | 0.00% | +33.3% |
| Q1 2023 | $9,119,156 | -29.7% | 238,347 | +0.7% | 0.00% | -25.0% |
| Q4 2022 | $12,965,516 | +78.7% | 236,597 | +11.1% | 0.00% | +33.3% |
| Q3 2022 | $7,254,000 | +365.6% | 213,019 | +29.2% | 0.00% | +200.0% |
| Q2 2022 | $1,558,000 | -36.7% | 164,823 | -5.0% | 0.00% | 0.0% |
| Q1 2022 | $2,463,000 | -33.2% | 173,546 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $3,686,000 | -0.3% | 174,252 | +5.4% | 0.00% | 0.0% |
| Q3 2021 | $3,696,000 | +7.2% | 165,353 | +19.0% | 0.00% | 0.0% |
| Q2 2021 | $3,449,000 | +7.0% | 138,993 | +25.1% | 0.00% | 0.0% |
| Q1 2021 | $3,224,000 | +15.8% | 111,111 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $2,785,000 | -16.1% | 107,932 | +0.1% | 0.00% | -50.0% |
| Q3 2020 | $3,320,000 | +161.4% | 107,813 | +111.6% | 0.00% | +100.0% |
| Q2 2020 | $1,270,000 | +35.1% | 50,945 | +14.9% | 0.00% | 0.0% |
| Q1 2020 | $940,000 | +16.9% | 44,326 | +22.4% | 0.00% | – |
| Q4 2019 | $804,000 | +9.4% | 36,224 | +12.2% | 0.00% | – |
| Q3 2019 | $735,000 | – | 32,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |